Clinical Oncology Education

Breakthrough in Blood Cancer: The QUIZOM Combination Therapy Offers New Hope for High-Risk AML Patients

• Clinical Oncology Education

Breakthrough in Blood Cancer: The QUIZOM Combination Therapy Offers New Hope for High-Risk AML Patients

Pevita Pearce June 23, 2026

In the high-stakes landscape of hematological oncology, few diagnoses carry as much weight as acute myeloid leukemia...

Read More Read more about Breakthrough in Blood Cancer: The QUIZOM Combination Therapy Offers New Hope for High-Risk AML Patients

A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma

• Clinical Oncology Education

A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma

Nila Kartika Wati June 22, 2026

In a landmark development for the field of hematology, researchers from the Dana-Farber Cancer Institute have unveiled...

Read More Read more about A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma

Breakthrough in Breast Cancer Treatment: ASCENT-04 Trial Data Suggests New Standard of Care for Metastatic Triple-Negative Breast Cancer

• Clinical Oncology Education

Breakthrough in Breast Cancer Treatment: ASCENT-04 Trial Data Suggests New Standard of Care for Metastatic Triple-Negative Breast Cancer

Asro June 22, 2026

As the medical community prepares to convene in Chicago for the 2026 American Society of Clinical Oncology...

Read More Read more about Breakthrough in Breast Cancer Treatment: ASCENT-04 Trial Data Suggests New Standard of Care for Metastatic Triple-Negative Breast Cancer

Landmark Study: Personalized mRNA Cancer Vaccine Sustains 49% Reduction in Melanoma Recurrence After Five Years

• Clinical Oncology Education

Landmark Study: Personalized mRNA Cancer Vaccine Sustains 49% Reduction in Melanoma Recurrence After Five Years

Suro Senen June 22, 2026

In a significant breakthrough for oncology, a long-term study has revealed that a personalized mRNA vaccine, when...

Read More Read more about Landmark Study: Personalized mRNA Cancer Vaccine Sustains 49% Reduction in Melanoma Recurrence After Five Years

The ADC Revolution: Redefining the Therapeutic Landscape for Primary Breast Cancer

• Clinical Oncology Education

The ADC Revolution: Redefining the Therapeutic Landscape for Primary Breast Cancer

Nana Wu June 21, 2026

In the rapidly evolving arena of oncology, few innovations have generated as much clinical anticipation as Antibody-Drug...

Read More Read more about The ADC Revolution: Redefining the Therapeutic Landscape for Primary Breast Cancer

Unmasking the ‘Hidden’ Network: How Lymph Node Structural Changes Could Revolutionize Breast Cancer Care

• Clinical Oncology Education

Unmasking the ‘Hidden’ Network: How Lymph Node Structural Changes Could Revolutionize Breast Cancer Care

Iffa Jayyana June 21, 2026

In a breakthrough that could fundamentally alter the landscape of breast cancer diagnostics and surgical intervention, a...

Read More Read more about Unmasking the ‘Hidden’ Network: How Lymph Node Structural Changes Could Revolutionize Breast Cancer Care

The Bottleneck of Hope: Bridging the Gap in Access to Advanced Breast Cancer Therapies

• Clinical Oncology Education

The Bottleneck of Hope: Bridging the Gap in Access to Advanced Breast Cancer Therapies

Evan Lee Salim June 20, 2026

Date: Wednesday, June 23, 2026 Time: 15:00 GMT Location: Global Virtual Symposium For thousands of patients living...

Read More Read more about The Bottleneck of Hope: Bridging the Gap in Access to Advanced Breast Cancer Therapies

Precision in a Drop: How Nanowire Technology is Revolutionizing Ovarian Cancer Detection

• Clinical Oncology Education

Precision in a Drop: How Nanowire Technology is Revolutionizing Ovarian Cancer Detection

Ali Ikhwan June 18, 2026

In the landscape of modern oncology, the "holy grail" of diagnostic medicine is the ability to detect...

Read More Read more about Precision in a Drop: How Nanowire Technology is Revolutionizing Ovarian Cancer Detection

Redefining Treatment for High-Risk Biochemically Recurrent Prostate Cancer: Insights from the EMBARK Trial

• Clinical Oncology Education

Redefining Treatment for High-Risk Biochemically Recurrent Prostate Cancer: Insights from the EMBARK Trial

Rifan Muazin June 18, 2026

The landscape of prostate cancer treatment has undergone a significant transformation in recent years, particularly regarding the...

Read More Read more about Redefining Treatment for High-Risk Biochemically Recurrent Prostate Cancer: Insights from the EMBARK Trial

Frontiers in Precision Oncology: The Rise of TCR-Modified Therapies for Pancreatic Cancer

• Clinical Oncology Education

Frontiers in Precision Oncology: The Rise of TCR-Modified Therapies for Pancreatic Cancer

Raul Delapena Setiawan June 17, 2026

The landscape of oncology is currently undergoing a seismic shift. For decades, pancreatic ductal adenocarcinoma (PDAC) has...

Read More Read more about Frontiers in Precision Oncology: The Rise of TCR-Modified Therapies for Pancreatic Cancer